| abstract |
This invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof with 5-HT4 agonist activities, which is useful in the treatment of dementia. This invention also relates to a pharmaceutical composition for the treatment of dementia and which comprises a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Furthermore, this invention relates to a method for the treatment of dementia in an animal subject, including a mammalian subject, which comprises administration to the animal subject, including a mammalian subject, of a compound of formula (I) or a pharmaceutically salt. acceptable from this one. (see formula (I)). |